Discover 1,437 paid clinical trials in New Braunfels, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,437
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
for
Melanoma
Location: Austin TX, Houston TX, Palestine TX, Fort Worth TX,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06246916
Phase 3, Recruiting
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Location: Austin TX, Houston TX, Dallas TX, Oklahoma City OK,
Sponsor: Kura Oncology, Inc.
Sex: All
Age: 18+
Code: NCT05735184
Phase 1, Recruiting
Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer
for
Bladder (Urothelial, Transitional Cell) Cancer,
Location: Austin TX, Houston TX, Arlington TX, Little Rock AR,
Sponsor: Protara Therapeutics
Sex: All
Age: 18+
Code: NCT07480356
Phase 3, Recruiting
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
for
Chronic Graft-Versus-Host Disease (cGVHD)
Location: Austin TX, Dallas TX, Westwood KS, St Louis MO,
Sponsor: Deciphera Pharmaceuticals, LLC
Sex: All
Age: 18+
Code: NCT06619561
Phase 2, Recruiting
A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms
for
Myeloproliferative Neoplasms
Location: Austin TX, Dallas TX, Denver CO, Phoenix AZ,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT07008118
Phase 1, Recruiting
Study Evaluating the Efficacy of KITE-753 Versus Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma After First-Line Therapy
for
Relapsed or Refractory Large B-cell Lymphoma
Location: Austin TX, St Louis MO, Nashville TN, Denver CO,
Sponsor: Kite, A Gilead Company
Sex: All
Age: 18+
Code: NCT07479797
Phase 3, Recruiting
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
for
Acute Treatment of Migraine
Location: Austin TX, Houston TX, Bellaire TX, El Paso TX,
Sponsor: Pfizer
Sex: All
Age: 6 - 17
Code: NCT04743141
Phase 3, Recruiting
Study of KITE-363 or KITE-753 in Participants With Relapsed and/or Refractory B-cell Lymphoma
for
Relapsed and/or Refractory B-cell Lymphoma
Location: Austin TX, Houston TX, Nashville TN, Gilbert AZ,
Sponsor: Kite, A Gilead Company
Sex: All
Age: 18+
Code: NCT04989803
Phase 1, Phase 2, Recruiting
Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of VH4011499 Compared to Placebo in Adults Without HIV
for
HIV Infections
Location: Austin TX, Las Vegas NV
Sponsor: ViiV Healthcare
Sex: All
Age: 18 - 55
Code: NCT06724640
Phase 1, Recruiting
A Study to Evaluate the Safety and Tolerability of Different Doses of CX11 Tablets
for
Obesity & Overweight
Location: Austin TX, Las Vegas NV
Sponsor: Corxel Pharmaceuticals
Sex: Female
Age: 18 - 55
Code: NCT07652047
Phase 1, Recruiting
A Comparative Study to Investigate the Difference in Blood Levels of Two Different Formulations of GSK5784283
for
Asthma
Location: Austin TX
Sponsor: GlaxoSmithKline
Sex: All
Age: 18 - 60
Code: NCT07712393
Phase 1, Recruiting
A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants
for
HIV Infections
Location: Austin TX, Las Vegas NV
Sponsor: ViiV Healthcare
Sex: All
Age: 18 - 55
Code: NCT05418868
Phase 1, Recruiting
Utility of PharmacoGenomics for Reducing Adverse Drug Effects
for
Genetics of Drug Metabolism
Location: Austin TX, Waco TX, League City TX, Pharr TX,
Sponsor: Companion Dx Reference Lab, LLC
Sex: All
Age: 18+
Code: NCT02081872
Recruiting
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine